About this Research Topic
Chronic Subdural Hematoma (cSDH) is a significant and growing concern in neurosurgery, especially within aging populations. By 2030, cSDH is expected to become one of the most frequently treated neurosurgical conditions in adults. The incidence of cSDH ranges from 1-4 per 100,000 annually in the general adult population but dramatically increases to 127 per 100,000 in individuals aged 80 and older. High-risk groups include elderly patients and those on anticoagulation or antiplatelet therapy. Traditional treatments like craniotomy and burr hole evacuation are commonplace, but recurrence rates remain a challenge.
This Research Topic aims to explore the emerging treatment of Middle Meningeal Artery Embolization (MMAE) for chronic subdural hematoma. MMAE offers a minimally invasive alternative that does not require general anesthesia, showing promising results in recent randomized controlled trials. The goal is to address the need for more extensive studies to evaluate the long-term efficacy, safety, and procedural optimization of MMAE. We seek to investigate how MMAE can be integrated into standard neurosurgical practice, potentially reducing recurrence rates and improving patient outcomes.
We invite a wide range of manuscript types, including original research, clinical trials, case reports, systematic reviews, and meta-analyses. Contributors are encouraged to focus on themes such as:
o Efficacy and safety of MMAE for cSDH treatment
o Long-term outcomes and follow-up studies on MMAE
o Comparative studies of MMAE versus traditional treatment methods like craniotomy and burr hole evacuation
o Patient selection criteria and risk assessment for MMAE
o Procedural techniques, including variations in embolic agents (e.g., liquid embolics, particles, coils)
o Complications associated with MMAE and their management
o Advances in embolic materials and technology
o Interdisciplinary care approaches and integration of MMAE into standard neurosurgical practice
This Research Topic aims to gather comprehensive insights into the potential of MMAE to revolutionize the treatment of chronic subdural hematoma, advancing both clinical practice and patient outcomes.
This Research Topic aims to explore the emerging treatment of Middle Meningeal Artery Embolization (MMAE) for chronic subdural hematoma. MMAE offers a minimally invasive alternative that does not require general anesthesia, showing promising results in recent randomized controlled trials. The goal is to address the need for more extensive studies to evaluate the long-term efficacy, safety, and procedural optimization of MMAE. We seek to investigate how MMAE can be integrated into standard neurosurgical practice, potentially reducing recurrence rates and improving patient outcomes.
We invite a wide range of manuscript types, including original research, clinical trials, case reports, systematic reviews, and meta-analyses. Contributors are encouraged to focus on themes such as:
o Efficacy and safety of MMAE for cSDH treatment
o Long-term outcomes and follow-up studies on MMAE
o Comparative studies of MMAE versus traditional treatment methods like craniotomy and burr hole evacuation
o Patient selection criteria and risk assessment for MMAE
o Procedural techniques, including variations in embolic agents (e.g., liquid embolics, particles, coils)
o Complications associated with MMAE and their management
o Advances in embolic materials and technology
o Interdisciplinary care approaches and integration of MMAE into standard neurosurgical practice
This Research Topic aims to gather comprehensive insights into the potential of MMAE to revolutionize the treatment of chronic subdural hematoma, advancing both clinical practice and patient outcomes.
Keywords: endovascular neurosurgery, interventional neuroradiology, chronic subdural hematoma, cSDH, middle meningeal artery embolization, MMAE
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
